OS from date of transplant according to pretransplant molecular MRD status. Panels A to C show the difference in survival between patients with positive and negative MRD (A) overall, (B) in the peripheral blood, and (C) in the bone marrow. Panels D to F show the difference in survival between patients with negative, low, and high levels of MRD (D) in the peripheral blood using a cutoff at 200 copies per 10⁵ABL, (E) in the bone marrow with level of more than 1000 copies, and (F) with either, defining high-level MRD. Percentages indicate estimated 2y-OS.